8.80
+0.15
+(1.73%)
At close: April 15 at 8:23:23 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 282.13M | 293.69M | 1.08B | 1.17B |
| Low Estimate | 281M | 286.8M | 1.08B | 1.14B |
| High Estimate | 284.1M | 298.5M | 1.09B | 1.2B |
| Year Ago Sales | 246M | 252M | 1B | 1.08B |
| Sales Growth (year/est) | 14.69% | 16.54% | 8.42% | 7.76% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UNS1.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Underweight to Underweight | 4/8/2025 |
| Upgrade | Rosenblatt: Neutral to Buy | 3/7/2025 |
| Maintains | Argus Research: Buy to Buy | 2/5/2025 |
| Maintains | UBS: Neutral to Neutral | 1/31/2025 |
| Maintains | B. Riley Securities: Neutral to Neutral | 1/31/2025 |
| Reiterates | Stifel: Buy to Buy | 1/31/2025 |